MedTrace Logo

ESH ABPM COVID-19 STUDY

NCT05167240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-12-22

No results posted yet for this study

Summary

Aim of the study is to determine the impact of the COVID-19 pandemic on blood pressure profiles and variability as assessed by ambulatory blood pressure monitoring (ABPM) through the comparison of ABPM data obtained before and during the COVID-19 lockdown in already treated hypertensive patients

Conditions

  • Ambulatory Blood Pressure

Sponsors & Collaborators

  • Jagiellonian University Collegium Medicum, Krakow, Poland

    collaborator UNKNOWN

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Andrzej Januszewicz, Prof · National Institute of Cardiology, Warszawa, Poland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-03
Primary Completion
2022-06-03
Completion
2022-12-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05167240 on ClinicalTrials.gov